Guardant Health - Kapitalisasi Buku GH

The price chart for Guardant Health, Inc. (GH) illustrates the price action of an asset valued at -0.22. Guardant Health, Inc. (GH) is innovating tumor monitoring via blood analysis, which, supported by insurance reimbursements, ensures a steady cash flow. The integration of services into medical centers strengthens B2B ties, although strict FDA oversight restricts the expansion of the customer base. Non-invasive screening technologies establish their solutions as the benchmark for personalized therapy selection.
Rincian metrik lan analitis perusahaan Guardant Health (GH)

Book value represents the difference between total assets and liabilities, reflecting the actual value of the company's equity for shareholders. By analyzing the history of net assets at book value, an investor assesses the financial stability of Guardant Health, Inc. (GH), determining how effectively revenues from liquid biopsy sales in the B2B and B2C segments translate into the growth of the issuer's fundamental capital.